Download PDF

Other users also viewed these articles

Efficacy and safety of using Elexacaftor/Tezacaftor/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil Guilherme da Silva Martins; Carolina Rambo; Gabriela Spessatto; Maitê Milagres Saab; Bruno Hernandes David João; Aline Didoni Fajardo; Juliana Gonçalves Primon; Thalita Gonçalves Picciani; Roberta Corrêa da Cunha; Herberto José Chong-Neto; Carlos Roberto Lebarbenchon Massignan; Luiz Vicente Ribeiro Ferreira da Silva-Filho; Carlos Antônio Riedi; Nelson Augusto Rosário Filho; Débora Carla Chong-Silva;
J Pediatr (Rio J). 2025;101:
Central auditory system assessment in children and adolescents with cystic fibrosis: electrophysiology and central auditory processing Paula Maria Martins-Duarte; Gabriel Hessel; Antônio Fernando Ribeiro; Fernando Augusto Lima Marson; Maria Francisca Colella-Santos;
J Pediatr (Rio J). 2025;101:96-102
Five-year performance analysis of a cystic fibrosis newborn screening program in northeastern Brazil Carolina Godoy; Danielle C. Paixão; Ney C.A. Boa-Sorte; Tatiana Amorim; Luiz Vicente R.F. da Silva Filho; Edna Lúcia Souza;
J Pediatr (Rio J). 2023;99:23-30